Good Documentation Practices (GDP) for Clinical Research

Value of the Information & Strength of the Argument

The presentation offers high practical value for clinical research professionals, translating regulatory requirements into actionable daily practices. It clearly explains the ALCOA+ framework and provides concrete examples of how to apply each principle, such as using single-line corrections and maintaining audit trails. The argumentation is solid, grounded in regulatory standards (ICH GCP, FDA, EMA) and institutional experience. The speaker’s expertise adds credibility, and the interactive scenarios reinforce learning. However, the presentation is primarily instructional rather than analytical, with limited critical discussion of potential challenges or alternative perspectives.

The title accurately reflects the content, which focuses on good documentation practices in clinical research.

8/10

The presentation is based on established regulatory frameworks (ICH GCP, FDA 21 CFR Part 11, EMA guidelines) and institutional SOPs. The speaker is a Quality Assurance Associate with direct expertise. The content is practical and aligns with widely recognized ALCOA principles. Minor limitations: no external citations provided, and some statements are institution-specific.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and importance of GDP in clinical research
• 02:00Overview of training requirements and options
• 05:00Explanation of acronyms: CRF, EDC, GCP, GLP, GMP
• 10:00Introduction to ALCOA principles and their regulatory basis
• 15:00Detailed explanation of Attributable and Legible principles
• 20:00Contemporaneous and Original principles with examples
• 25:00Accurate principle and the additional ALCOA+ elements
• 30:00Signatures and electronic documentation best practices
• 35:00Versioning and error correction procedures
• 40:00Interactive scenarios and Q&A session

• ICH GCP E6(R3) — Referenced as the international standard for clinical research and the basis for updated training requirements.
• FDA 21 CFR Part 11 — Mentioned as a regulation where ALCOA is explicitly included for electronic records.
• EMA Guidelines — Referenced for the addition of ALCOA+ principles in 2010.

• ICH GCP E6(R3) — The presentation aligns with the updated ICH GCP guidelines, which emphasize data integrity and documentation practices.
• FDA 21 CFR Part 11 — The discussion on electronic signatures and audit trails is consistent with FDA requirements for electronic records.